Clorox director awarded deferred stock units

Clorox director Christopher J. Williams reported routine compensation-related awards of Deferred Stock Units.

Rhea-AI Filing Summary

Clorox director Christopher J. Williams reported routine compensation-related awards of Deferred Stock Units. He acquired 265.3672 units on March 31, 2026 and 212.6390 units on February 13, 2026, with each unit representing one share of Clorox common stock.

Some units were acquired through dividend reinvestment under the Independent Directors' Deferred Compensation Plan and some in lieu of quarterly director fees. These Deferred Stock Units will be settled entirely in Clorox stock when Williams retires or otherwise leaves the board, bringing his reported Deferred Stock Unit balance to 22,074.5818 units held directly.

Insider Trade Summary

Grant/Award: 478.0062 shares

Grant/Award 2 txns

Insider WILLIAMS CHRISTOPHER J

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock Units	265.3672	$0.00	$0.00
Grant/Award	Deferred Stock Units	212.639	$0.00	$0.00

Holdings After Transaction: Deferred Stock Units — 22,074.5818 contracts (Direct)

Footnotes (4)

1. F1. 1-for-1
2. F2. Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
3. F3. The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
4. F4. Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees.

Key Figures

Deferred Stock Units granted: 265.3672 units Deferred Stock Units granted: 212.6390 units Deferred Stock Units held: 22,074.5818 units

3 metrics

Deferred Stock Units granted 265.3672 units Award on March 31, 2026

Deferred Stock Units granted 212.6390 units Award on February 13, 2026

Deferred Stock Units held 22,074.5818 units Total following March 31, 2026 transaction

Key Terms

Deferred Stock Units, Independent Directors' Deferred Compensation Plan, dividend reinvestment, quarterly director's fees

4 terms

Deferred Stock Units financial

"Deferred Stock Units acquired through dividend reinvestment during the fiscal year"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

Independent Directors' Deferred Compensation Plan financial

"Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan."

A deferred compensation plan for independent directors lets outside board members postpone receiving part of their fees or stock awards until a later date, often when they retire or leave the board. Think of it as choosing to put pay into a company-run savings plan that grows and pays out later; it matters to investors because it affects director incentives, future cash or share obligations, and how aligned independent directors are with long-term company performance.

dividend reinvestment financial

"Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan."

Dividend reinvestment is when the money earned from a company's profit sharing, called dividends, is automatically used to buy more shares of that company instead of being received as cash. This process helps investors grow their holdings over time without extra effort, much like using earned interest to buy more of a savings account. It encourages long-term investment growth by continuously increasing the amount of shares owned.

quarterly director's fees financial

"Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Clorox (CLX) director Christopher J. Williams report?

Christopher J. Williams reported acquiring Deferred Stock Units as part of his director compensation. He received 265.3672 units on March 31, 2026 and 212.6390 units on February 13, 2026, all as direct holdings, with each unit tied to Clorox common stock.

Are the recent Form 4 transactions for CLX a stock purchase or sale?

The Form 4 for CLX shows no open-market buys or sells. Instead, it records awards of Deferred Stock Units as compensation, including amounts received via dividend reinvestment and in lieu of quarterly director fees, which will be settled later in Clorox stock.

How many Deferred Stock Units does Christopher J. Williams hold after these CLX transactions?

Following the reported awards, Christopher J. Williams holds 22,074.5818 Deferred Stock Units directly. This total reflects the cumulative balance after the March 31, 2026 grant and represents units that will convert into Clorox common stock upon his retirement or service termination.

What are Deferred Stock Units in the context of Clorox (CLX) director compensation?

Deferred Stock Units are bookkeeping entries tied 1-for-1 to Clorox common shares. For the director, some units are received via dividend reinvestment and some instead of cash quarterly fees, with all units payable in Clorox stock after board service ends.

When will Christopher J. Williams receive actual CLX shares from these Deferred Stock Units?

The Deferred Stock Units will be settled entirely in Clorox stock when Christopher J. Williams retires or otherwise terminates his service as a director. Until then, they remain deferred compensation units linked to the company’s common stock on a one-for-one basis.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/02/2026 - 04:16 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WILLIAMS CHRISTOPHER J

(Last) (First) (Middle)

1221 BROADWAY

(Street)

OAKLAND CALIFORNIA 94612-1888

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CLOROX CO /DE/ [ CLX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	(1)	02/13/2026		A(2)	V	212.639		(3)	(3)	Common Stock	212.639	$0.0000	21,809.2146	D
Deferred Stock Units	(1)	03/31/2026		A(4)		265.3672		(3)	(3)	Common Stock	265.3672	$0.0000	22,074.5818	D

Explanation of Responses:

1. 1-for-1

2. Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.

3. The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.

4. Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees.

	By Jinho Joo, Attorney-in-Fact	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)